髋关节发育不良既往非手术或手术治疗是否与髋臼周围截骨术较差结果相关?
该回顾性对照研究分析71例既往治疗(手术或非手术)后行PAO的DDH髋与142例无既往治疗对照髋,发现两组功能评分改善幅度无临床重要差异,但既往治疗组术前畸形更重、影像学矫正欠完整且并发症更多;亚组中既往手术组关节炎进展更常见。
要点
- 既往治疗组与对照组在mHHS、iHOT-12、WOMAC改善幅度上无临床重要差异。
- 既往治疗组术前畸形更重,末次随访时影像学参数差异小且均值在正常范围。
- 既往治疗组术中后柱骨折、髋臼覆盖不足和骨关节炎进展风险更高。
核心结论
- 既往儿童期治疗与未治疗患者PAO术后功能改善幅度无临床重要差异,但既往治疗者更易发生严重并发症且影像学矫正欠完整。
- 作者认为不应忽视既往非手术治疗后残余DDH的意外严重畸形及PAO术后并发症。
- 作者指出外科医生和患者应知晓既往手术或非手术治疗后行PAO可能影像学结果更差或并发症风险增加。
研究设计与样本
- 回顾性对照研究,纳入2011年1月至2020年12月间因DDH行PAO且有既往治疗史的患者71例(71髋)为既往治疗组。
- 同期无既往髋治疗史行PAO的患者中按1:2比例匹配年龄、手术年份和随访时间选取142例(142髋)为对照组。
- 既往治疗组中32例有既往手术史(既往手术组),39例有既往非手术治疗史(既往非手术组)。
主要发现
- 既往治疗组与对照组mHHS改善分别为10±12 vs 12±12(p=0.36),iHOT-12改善分别为25±18 vs 26±19(p=0.51),WOMAC改善分别为12±12 vs 15±19(p=0.17),均无临床重要差异。
- 既往治疗组术前LCEA为-1°±9° vs 对照组5°±8°,ACEA为-8°±18° vs 1°±14°,Tönnis角为31°±7° vs 27°±7°,髋臼头指数为56%±13% vs 61%±8%,均p<0.001。
- 既往治疗组股骨头变平或不规则比例为52% vs 对照组9%(p<0.001),Tönnis分级1级及以上比例为51% vs 42%(p<0.001)。
- 既往治疗组术中后柱骨折风险为14% vs 对照组5%(p=0.02),髋臼覆盖不足为20% vs 8%(p=0.01),骨关节炎进展为17% vs 8%(p=0.04)。
- 亚组分析中既往手术组与既往非手术组mHHS改善为10±14 vs 10±11(p=0.91),iHOT-12为22±21 vs 27±14(p=0.26),WOMAC为12±14 vs 12±11(p=0.94),均无临床重要差异。
关键数值与推荐
- mHHS、iHOT-12和WOMAC的临床重要改善阈值分别为9.6分、16.1分和13分。
- 既往手术组关节炎比例为72% vs 既往非手术组34%(p=0.01),前壁指数为11%±11% vs 20%±12%(p=0.01)。
- 既往手术组关节炎进展频率为28% vs 既往非手术组8%(p=0.02)。
- 既往手术组与既往非手术组耻骨支不愈合频率为22% vs 21%(p=0.89),术中后柱骨折为19% vs 10%(p=0.50),髋臼覆盖不足为25% vs 15%(p=0.31)。
临床怎么用
- 作者指出对于既往手术或非手术治疗后行PAO的患者,外科医生和患者应知晓可能影像学结果更差或并发症风险增加。
- 作者认为未来研究可能探索该特定患者群体的最佳管理策略以改善结果和减少并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Understanding the implications of either nonoperative or operative treatment of developmental dysplasia of the hip (DDH) performed before periacetabular osteotomy (PAO) is critical to counseling patients and their families. There are limited studies, however, on PAO for the treatment of residual DDH after surgical intervention during childhood, and even less information about PAO after prior nonoperative treatment. QUESTIONS/PURPOSES: We analyzed patients who had undergone PAO for DDH and asked: Did patients with prior childhood treatment (either operative or nonoperative) (1) improve less in modified Harris hip score (mHHS), 12-item International Hip Outcome Tool (iHOT-12) score, or WOMAC score; (2) demonstrate more severe preoperative deformities; and (3) receive less complete radiographic correction and have more frequent complications than did patients whose hips had not undergone prior treatment? We also asked: (4) Were there subgroup differences among patients with DDH treated nonoperatively versus operatively before PAO in these same functional and radiographic parameters? METHODS: Between January 2011 and December 2020, a total of 90 PAOs were performed in 82 patients who had prior surgical or nonsurgical treatment. Of those, 3 patients (3 hips) with neuromuscular diseases were excluded, 4 patients (5 hips) were excluded for having received treatment after childhood, 7 hips that had undergone bilateral PAOs were excluded, and another 4 patients (4 hips) were lost to follow-up before the minimum study period of 2 years, leaving 71 patients (71 hips) for analysis (the previous treatment group). Among these, 32 patients had a history of previous surgery (the previous surgery group), and 39 patients had prior nonsurgical treatment (such as a Pavlik harness, closed reduction, spica casting) (the previous nonoperative group). During the same period, 1109 PAOs were performed in 956 patients who had no history of previous hip treatment. Following a 1:2 ratio, 142 patients (142 hips) were selected as the control group by matching for age (within 2 years difference), year of surgery (same year), and follow-up time (within 1-year difference). The patient characteristics for both the previous treatment group and the control group exhibited comparability, with mean ± SD follow-up durations of 49 ± 23 months and 48 ± 19 months, respectively. Within the previous 5 years, 3 patients (8%) in the previous nonoperative group, 4 patients (13%) in the previous surgery group, and 15 patients (11%) in the control group had not attended follow-up visits. We compared hip function and radiographic results between the two groups and performed a subgroup analysis between the previous surgery group and the previous nonoperative group. Hip function was assessed using the mHHS questionnaire, the WOMAC, and the iHOT-12 with attention to the minimum clinically important differences of these tools. The threshold values for clinically important improvement were 9.6 points, 13 points, and 16.1 points for the mHHS, iHOT-12, and WOMAC, respectively. Radiographic measurements included the lateral center-edge angle (LCEA), anterior center-edge angle (ACEA), Tönnis angle, acetabulum-head index, and acetabular wall index. We also evaluated Tönnis osteoarthritis grade and femoral head deformity. Occurrences of adverse radiographic events such as posterior column fracture, nonunion, stress fractures, insufficient coverage or overcoverage, acetabular protrusion, and progression of osteoarthritis were recorded. RESULTS: We found no clinically important differences in magnitude of improvement between the previous treatment group and the control group in terms of mHHS (mean ± SD 10 ± 12 versus 12 ± 12; p = 0.36), iHOT-12 (25 ± 18 versus 26 ± 19; p = 0.51), or WOMAC score (12 ± 12 versus 15 ± 19; p = 0.17). Preoperative deformity in the previous treatment group was more severe than in the control group (mean ± SD LCEA -1° ± 9° versus 5° ± 8°; ACEA -8° ± 18° versus 1° ± 14°; Tönnis angle 31° ± 7° versus 27° ± 7°; acetabulum-head index 56% ± 13% versus 61% ± 8%; all p < 0.001). In the previous treatment group, a higher percentage of patients exhibited flattening or irregularity of the femoral head compared with the control group (52% versus 9%; p < 0.001), and there was also a higher proportion of patients with Tönnis grade 1 or above (51% versus 42%; p < 0.001). Although there were still differences in LCEA, ACEA, and Tönnis angle between the two groups at the last follow-up, the differences were small, and the mean values were within the normal range. The previous treatment group had a higher risk of intraoperative posterior column fracture (14% and 5%; p = 0.02), insufficient acetabular coverage (20% and 8%; p = 0.01), and progression of osteoarthritis (17% and 8%; p = 0.04) compared with the control group. Subgroup analysis revealed no clinically important differences in magnitude of improvement between the previous surgery group and the previous nonoperative group in terms of mHHS (10 ± 14 versus 10 ± 11; p = 0.91), iHOT-12 (22 ± 21 versus 27 ± 14; p = 0.26), or WOMAC score (12 ± 14 versus 12 ± 11; p = 0.94). Apart from a higher proportion of patients who presented with arthritis (72% versus 34%; p = 0.01) and a smaller anterior wall index (11% ± 11% versus 20% ± 12%; p = 0.01) in the previous surgery group, all other preoperative radiographic parameters were consistent between the two groups. Additionally, the previous surgery group had a higher frequency of arthritis progression (28% versus 8%; p = 0.02), while the frequencies of other complications were similar between the two groups. Specifically, the frequencies of pubic ramus nonunion (22% versus 21%; p = 0.89), intraoperative posterior column fracture (19% versus 10%; p = 0.50), and insufficient acetabular coverage (25% versus 15%; p = 0.31) were high in both groups. CONCLUSION: We found no clinically important difference in the magnitude of improvement between patients who had childhood treatment and those who did not, but patients who had prior childhood treatment were more likely to experience serious complications, and radiographic correction in those patients was less complete. As in the case of patients who have had prior operative treatments, it is crucial not to overlook the unexpectedly severe deformity of residual DDH after previous nonoperative treatment and complications following PAO. Surgeons and patients alike should be aware of the potential for worse radiographic outcomes or an increased risk of complications when prior operative or nonoperative treatment has preceded PAO. Future studies might investigate optimal management strategies for this specific group of patients to improve outcomes and reduce complications. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Zhang Z, Cheng N, Jia H, et al. Is Prior Nonoperative or Operative Treatment of Dysplasia of the Hip Associated With Poorer Results of Periacetabular Osteotomy? Clin Orthop Relat Res. 2024. PMID: 38917051. doi:10.1097/CORR.0000000000003150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。